Send to a Friend Font Size: Increase Decrease

AKRO and NXTC Related Headlines

Jul 14, 2026 06:01AM NextCure and Avere to merge, targeting oral IL-23 therapy
Jul 14, 2026 06:00AM NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

AKRO and NXTC Related Press Releases

Jul 14, 2026 06:00AM NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

AKRO and NXTC Related SEC Filings